破解激酶代码:尿路生物标志物作为AAA破裂-A试点研究的早期警报
Emma Maria Östling1, Tomas Baltrunas2,3, Nathalie Grootenboer1
1Department of Vascular Surgery, Hospitalsenhed Midt, 8800 Viborg, Denmark.
Journal of clinical medicine
|June 13, 2025
概括
研究人员确定了六种尿氨酸激酶作为检测破裂腹腔大动脉动脉瘤 (RAAA) 的潜在生物标志物. 这种非侵入性方法可以帮助早期诊断和对这种危及生命的血管疾病的风险分层.
科学领域:
- 生物化学 生物化学
- 蛋白质组学是指蛋白质组学.
- 血管生物学 血管生物学
背景情况:
- 破裂腹腔大动脉动脉瘤 (RAAA) 的死亡率很高 (近90%).
- 临床需要生物标志物来识别高风险个体.
- 具有破裂风险的腹腔大动脉动脉瘤 (AAA) 的非侵入性检测方法至关重要.
研究的目的:
- 为了识别尿蛋白质组的潜在变化,以进行AAA的非侵入性检测.
- 发现尿路生物标志物,以识别具有高破裂风险的AAA.
主要方法:
- 使用多重激酶抑制剂珠 (MIBs) 和定量质谱 (MIB/MS) 进行尿蛋白组分析.
- 雇员 iTRAQ 标签和LC-TEMPO MALDI-TOF/TOF用于定量蛋白质基因分析.
- 通过Western blot验证发现,并使用R/Bioconductor和开源生物信息学工具分析数据.
主要成果:
- 量化测量了130多个激酶的活性,确定了EPHB6,AXL,EPHB4,DDR1,EPHA2和EPHB3中的显著失调.
- 所有已识别的显著蛋白质都是氨酸激酶,其中以弗林受体类型占主导地位.
- 通过Western blot证实了观察到的特定激酶的减少表达.
结论:
- 确定了六种失调的尿氨酸激酶作为RAAA的潜在生物标志物.
- 这些发现表明,AAA早期检测和风险评估是一种有希望的非侵入性方法.
- 需要在更大的潜在队列中进一步验证,以确认诊断效用和通用性.
更多相关视频
相关概念视频
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
119
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
119
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
69
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
69


